Structure/Function Studies on QS-21, A Unique Immunological Adjuvant from Quillaja saponaria
Authors:
- 1 January 1996
- book chapter
- Published by Springer Nature
- Vol. 404, 165-172
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Isomerization and Formulation Stability of the Vaccine Adjuvant QS-21Journal of Pharmaceutical Sciences, 1996
- DS-1, a Modified Quillaja Saponin, Enhances Ocular and Nasal Absorption of InsulinJournal of Pharmaceutical Sciences, 1995
- Formulation Of An Immunogenic Human Cytomegalovirus Vaccine: Responses In MiceThe Journal of Infectious Diseases, 1995
- Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in mice that are similar to those generated by experimental infectionVaccine, 1995
- Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccinesVaccine, 1995
- Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant functionVaccine, 1995
- Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.Journal of Experimental Medicine, 1992
- Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMsNature, 1990
- Introduction of soluble protein into the class I pathway of antigen processing and presentationCell, 1988
- Structures of compounds derived from the acyl moieties of quillajasaponinPhytochemistry, 1987